2019
PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer. Clin Cancer Res. 2019;25(22):6839-6851.
Reply to 'H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines'. Nat Genet. 2019;51(10):1427-1428.
A thermo-sensitive fluorescent agent based method for excitation light leakage rejection for fluorescence molecular tomography. Phys Med Biol. 2019;64(3):035007.
Evaluation of peripheral blood mononuclear cell collection by leukapheresis. Transfusion. 2019;59(5):1765-1772.
A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma. Blood. 2019;133(11):1201-1204.
The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3. Cancer Res. 2019;79(12):3076-3087.
Tubular brain tumor biopsy improves diagnostic yield for subcortical lesions. J Neurooncol. 2019;141(1):121-129.
PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance. Mol Cancer Res. 2019;17(2):618-627.
